Erika Di Biase

Milan, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 24 publications

APOE3 astrocytes can rescue lipid abnormalities and dystrophic neurites of APOE4 human neurons.

APOE3 astrocytes can rescue lipid abnormalities and dystrophic neurites of APOE4 human neurons.

Journal: bioRxiv : the preprint server for biology

Published: November 24, 2025

APOE3 astrocytes can rescue lipid abnormalities and dystrophic neurites of APOE4 human neurons.

APOE3 astrocytes can rescue lipid abnormalities and dystrophic neurites of APOE4 human neurons.

Journal: PNAS nexus

Published: October 27, 2025

Metabolic and Structural Consequences of GM3 Synthase Deficiency: Insights from an HEK293-T Knockout Model.

Metabolic and Structural Consequences of GM3 Synthase Deficiency: Insights from an HEK293-T Knockout Model.

Journal: Biomedicines

Published: February 20, 2025

ApoE4 requires lipidation enhancement to resolve cellular lipid and protein abnormalities following NPC1 inhibition.

ApoE4 requires lipidation enhancement to resolve cellular lipid and protein abnormalities following NPC1 inhibition.

Journal: Scientific reports

Published: October 15, 2024

GM1 structural requirements to mediate neuronal functions.

GM1 structural requirements to mediate neuronal functions.

Journal: Glycoconjugate journal

Published: September 20, 2023

Loss of Lipid Carrier ApoE Exacerbates Brain Glial and Inflammatory Responses after Lysosomal GBA1 Inhibition.

Loss of Lipid Carrier ApoE Exacerbates Brain Glial and Inflammatory Responses after Lysosomal GBA1 Inhibition.

Journal: Cells

Published: August 04, 2023

GM1 ganglioside exerts protective effects against glutamate-excitotoxicity via its oligosaccharide in wild-type and amyotrophic lateral sclerosis motor neurons.

GM1 ganglioside exerts protective effects against glutamate-excitotoxicity via its oligosaccharide in wild-type and amyotrophic lateral sclerosis motor neurons.

Journal: FEBS open bio

Published: July 19, 2023

GM1 oligosaccharide efficacy against α-synuclein aggregation and toxicity in vitro.

GM1 oligosaccharide efficacy against α-synuclein aggregation and toxicity in vitro.

Journal: Biochimica et biophysica acta. Molecular and cell biology of lipids

Published: April 05, 2023

GM1 Oligosaccharide Efficacy in Parkinson's Disease: Protection against MPTP.

GM1 Oligosaccharide Efficacy in Parkinson's Disease: Protection against MPTP.

Journal: Biomedicines

Published: April 05, 2023

Regulation of signal transduction by gangliosides in lipid rafts: focus on GM3-IR and GM1-TrkA interactions.

Regulation of signal transduction by gangliosides in lipid rafts: focus on GM3-IR and GM1-TrkA interactions.

Journal: FEBS letters

Published: April 06, 2022

Glycosphingolipids.

Glycosphingolipids.

Journal: Advances in experimental medicine and biology

Published: September 08, 2021

Novel insights on GM1 and Parkinson's disease: A critical review.

Novel insights on GM1 and Parkinson's disease: A critical review.

Journal: Glycoconjugate journal

Published: May 12, 2021

Showing 1-12 of 24

Last Updated: 09/26/2026